JPRN-UMIN000003648已完成2 期
A phase II study of allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using intravenous busulfan and cyclophosphamide as conditioning regimen. - KSGCT1002/C-SHOT1003
Kanto Study Group for Cell Therapy Nagoya Blood and Marrow Transplantation (NBMT) Group0 个研究点目标入组 40 人开始时间: 2010年6月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 55years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with uncontrolled diabetes mellitus in spite of regular use of insulin (2) Patients with uncontrolled hypertension in spite of use of antihypertensive drugs (3) Patients who have active infection (4) Patients who are positive for TPHA, HBV surface antigen, or anti-HCV antibody. (5) Patients who are positive for anti-HTLV-I or anti-HIV antibody (6) Patients who are not evaluated to be able to survive more than 100 days after transplantation (7) Patients who have coinciding active malignancies (8) Patients who are pregnant or in the lactation period (9) Patients who have psychiatric disorder (10) Patients who have prior hematopoietic stem cell transplantation (11) Patients who are considered as inappropriate to register by attending physicians
研究者
相似试验
已完成
2 期
Phase II study of allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using once daily intravenous busulfan and fludarabine as conditioning regimeacute myeloid leukemia(AML) myelodysplastic syndrome(MDS) chronic myelogenous leukemia(CML)JPRN-UMIN000009766Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital75
招募中
2 期
Phase II study of allogeneic hematopoietic stem cell transplantation using a preparative regimens consisting of iv Bu + Flu + L-PAM for patients with juvenile myelomonocytic leukemia (JMML)Juvenile myelomonocytic leukemia (JMML)JPRN-UMIN000005936Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)43
招募中
2 期
AML-SCT15acute myeloid leukemia (AML)JPRN-jRCTs051180190YABE Hiromasa66
招募中
2 期
Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as a conditioning regimen (AML-SCT15).acute myeloid leukemia (AML)JPRN-UMIN000027821Japan Children's Cancer Group (JCCG)66
招募中
不适用
Clinical Phase II Study of hematopoietic stem ctell transplantation for ataxia telangiectasia and related diseasesataxia telangiectasia DNA damage response disorderJPRN-UMIN000019532Graduate Schoool, Dept. of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University5